Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Airas L et al. |
Encephalitis associated with Chlamydia pneumoniae.
|
2 |
Anichtchik OV et al. |
Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
|
3 |
Bath PMW et al. |
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
|
4 |
Broberg E et al. |
Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
|
5 |
Brück A et al. |
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson´s disease is related to dopaminergic hypofunction in the caudate nucleus.
|
6 |
Haapaniemi J et al. |
Botulinum toxin in the treatment of cricopharyngeal dysphagia.
|
7 |
Jääskeläinen S et al. |
Role of the dopaminergic system in chronic pain - a fluorodopa-PET study.
|
8 |
Kaasinen V et al. |
Personality traits and brain dopaminergic function in Parkinson´s disease .
|
9 |
Kaasinen V et al. |
Increased frontal (18F)flurodopa uptake in early Parkinson´s disease: sex differences in the prefrontal cortex.
|
10 |
Kaasinen V. et al. |
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.
|
11 |
Kemppainen N et al. |
Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing.
|
12 |
Lamusuo S et al. |
[18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.
|
13 |
Lamusuo S. |
Imaging the Epileptogenic Region with Positron Emission Tomography in Patients with Temporal Lobe Epilepsy.
|
14 |
Lee M. et al. |
Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson´s disease.
|
15 |
Lilja AM et al. |
Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors.
|
16 |
Mattila PM et al. |
Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
|
17 |
Nurmi E. |
Progression of Nigrostrial Hypofunction in Parkinson´s Disease.
|
18 |
Nurmi E et al. |
The rate of progression in Parkinson´s disease: a 6-(18F) fluoro-L-dopa PET study.
|
19 |
Rinne JO et al. |
(18F)FDOPA and (18F)CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson´s disease.
|
20 |
Ruottinen HM et al. |
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's diasease requires prolong imaging.
|
21 |
Tuominen S et al. |
Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation.
|
22 |
Åberg L. et al. |
A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis.
|